Zelira Therapeutics Limited (ZLDAF) .
이 페이지에서 입증된 기준:
SharesGrow 종합 점수: 5/100 0/7 개 기준 통과.
| Year | EPS (희석) | 매출 | 순이익 | 순이익률 |
|---|---|---|---|---|
| 2016 | $-1.39 | $300K | $-898.64K | -299.5% |
| 2017 | $-2.18 | $100.04K | $-6.16M | -6154.8% |
| 2018 | $-0.40 | $313.76K | $-1.73M | -551.3% |
| 2019 | $-0.83 | $769.03K | $-3.57M | -463.9% |
| 2020 | $-1.45 | $0.00 | $-7.02M | - |
| 2021 | $-1.29 | $663.32K | $-8.55M | -1288.8% |
| 2022 | $-1.49 | $1.54M | $-11.95M | -775.4% |
| 2023 | $-0.55 | $301.12K | $-5.57M | -1850.8% |
| 2024 | $-3.22 | $94.95K | $-36.57M | -38513% |
| 2025 | $-0.32 | $656.00 | $-3.63M | -553029.3% |
